Showing results (1061-1070 of 1,797) with videos related to
Sort By:
Pageof 180
Mabs|December 19, 2019
Antibodies to watch in 2020Hélène Kaplon, Mrinalini Muralidharan, Zita Schneider, et al.Mabs|January 12, 2020
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosisSarah Low, Haixia Wu, Kavita Jerath, et al.Mabs|January 14, 2020
Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding siteKarl J M Hanf, Joseph W Arndt, YuTing Liu, et al.Mabs|December 20, 2019
Harnessing MerTK agonism for targeted therapeuticsVivekananda Kedage, Diego Ellerman, Yongmei Chen, et al.Mabs|May 31, 2022
Enzymatic glycan remodeling-metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineeringMarloes A Wijdeven, Remon van Geel, Jorin H Hoogenboom, et al.Mabs|December 6, 2018
Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeuticsStefan Harth, Andre Ten Haaf, Christian Loew, et al.Mabs|December 8, 2018
In vitro and in silico assessment of the developability of a designed monoclonal antibody libraryAdriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen, et al.Mabs|December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo propertiesAyse Meric Ovacik, Ji Li, Marie Lemper, et al.Mabs|March 20, 2018
Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumabNeungseon Seo, Alla Polozova, Mingxuan Zhang, et al.Pageof 180